At Virta, two of our company’s core values are Evidence-based and Transparency. This goes for our conduct within Virta, as well as how we engage with our partners, the public, and most importantly, our patients.

With that in mind, I am excited to announce that our ongoing clinical trial’s cardiovascular health outcomes were just published in Cardiovascular Diabetology. This study is momentous because it marks the beginning of our publications on how the Virta Treatment impacts health beyond type 2 diabetes reversal. Also, at a higher level, it challenges our society’s implicit acceptance that medical treatments will improve one condition at a time or even at the expense of another.

What does the Virta treatment do beyond type 2 diabetes reversal?
Today’s publication continues to answer this question. We systematically tracked and reviewed 26 parameters associated with cardiovascular disease in our clinical trial. Nearly all (22) of these parameters showed significant improvement following 1-yr of the Virta treatment, while zero showed significant improvement in those receiving usual type 2 diabetes care.

Of particular note are the following:

  • A reduction in both systolic and diastolic blood pressure
  • An 11.9% reduction in 10-year ASCVD (atherosclerotic cardiovascular disease) risk score
  • A substantial prescription reduction for hypertension medications
  • A 39% decrease in inflammation (measured by C-reactive protein)

These findings happened in concert with weight loss and type 2 diabetes reversal—60% of our patients saw type 2 diabetes reversed at 1 year. For payers, this translates into an estimated $9600 per patient over the first 2 years of treatment.

For additional analyses of these markers of cardiovascular disease risk, Virta co-founders Drs. Stephen Phinney and Jeff Volek provide a scientific deep-dive in a way only they can. We have also summarized the cardiovascular benefits of the Virta Treatment in a downloadable white paper.

What’s next?
Our team couldn’t be happier with these results. Cardiovascular disease is the number one cause of morbidity and mortality in patients with type 2 diabetes, and these findings give hope to 30 million Americans and their loved ones that they can safely lower their blood glucose levels and improve their cardiovascular health without expensive drugs or complex medical procedures. Yet, even with these outcomes, our research and clinical teams are more dedicated than ever to a scientific and evidence-based approach to improving the Virta Treatment for our patients.

Dr. Sarah Hallberg on the one-year results of the Virta Treatment

10 Comments

  1. Mary Kay Osborne May 3, 2018 at 8:07 pm

    I really need this!

    Reply

    1. We can help!
      You can apply directly or let us know who your employer / health plan is so we can make sure Virta Treatment is covered for you.
      Best,
      Sami

      Reply

  2. What about “hyper-responders”? Any data on long term CV implications for patients who see a double or tripple increase in LDL-P and LDL-C on a ketogenic diet?

    Reply

    1. Virta Health
      Virta Health May 4, 2018 at 4:24 pm

      Thanks for your question! We have a more in-depth look at our cardiovascular data here: https://blog.virtahealth.com/blood-lipid-changes-with-ketogenic-diet/

      Reply

  3. It is difficult to tell what “Virta treatment” involves in a simple manner. I would love to share this evidence with my clients, however, from the pages I read, it is very difficult to make the direct link between nutritional ketosis and the published results.
    Is there a page with your methodology in laymen’s terms that would be easier for those that aren’t so scientifically literate to understand?
    Thank you very much in advance, and thank you for doing amazing work saving lives and restoring quality of life and health for so many people!!!

    Reply

    1. Virta Health
      Virta Health May 9, 2018 at 4:30 pm

      Thanks! Here’s a description of the treatment (and there’s a video with a clearer explanation): https://www.virtahealth.com/thevirtatreatment

      Reply

  4. I’m a 67 year old male with cardiovascular disease. Two stents in 2001. Being on Medicare is your treatment something that would apply to me.

    Reply

    1. Virta Health

      Most of our existing patients come in through their employer-sponsored health plans, and for these patients, Virta is free and a fully-covered benefit. We also offer an out of pocket option which costs about $370 per month and a patient assistance program to help cover the costs for those who qualify. We are covered by select insurance plans (but unfortunately not Medicare yet) and are working hard to make Virta available to everyone through insurance. You can learn more and apply here: https://www.virtahealth.com/thevirtatreatment

      Reply

  5. Prashant Gokhale June 28, 2018 at 12:49 pm

    The link to the CVD white paper turns up a blank page. Could I pls have a copy of the white paper

    Regards

    Reply

    1. Virta Health

      Thanks for letting us know! Try this page: https://about.virtahealth.com/CVD-whitepaper

      Reply

Leave a reply

Your email address will not be published.